Abstract
Background
There are little data available on complication rates following primary total hip arthroplasty (THA) surgery in Ireland.
Aims
To determine self-reported complication rates and national data for primary THA.
Methods
A postal questionnaire surveyed Irish orthopaedic association consultant members. Additional data were obtained from the economic and social research institute (ESRI).
Results
We achieved an 83% response rate. 5,424 THAs were self-reported. Mean dislocation rates were 1%, but higher using a posterior surgical approach (p < 0.05). Mean deep infection rates were 0.4%. 29% were MRSA. No reduction was reported from additional barrier prophylaxes. Mean venous thrombo-embolism (VTE) rates were 3.5%. No reduction was reported from commencing prophylaxis preoperatively or extending treatment duration. National rates for dislocation, deep infection and VTE were 25.7, 0.87, and <0.1%, respectively.
Conclusions
The creation of a National Hip Register is strongly recommended. A register would improve surgical practices and patient outcomes, and provide significant healthcare savings.
Similar content being viewed by others
References
Callaghan JJ, Templeton JE, Liu SS et al (2004) Results of Charnley total hip arthroplasty at a minimum of thirty years. A concise follow-up of a previous report. JBJS(Am) 86(A(4)):690–695
Herberts P, Malchau H (2000) Long term registration has improved the quality of hip replacement: a review of the Swedish THR register comparing 160, 000 cases. Acta Orthop Scand 71:111–121
Malchau H, Herberts P, Eisler T et al (2002) The Swedish total hip replacement register. JBJS (Am) 84(Suppl. 2):2–20
Wroblewski MB, Siney PD, Fleming PA (2002) Charnley low-frictional torque arthroplasty in patients under the age of 51 years. Follow-up to 33 years. JBJS(Br) 84(B, (4)):540–543
Woo RY, Morrey BF (1982) Dislocations after total hip arthroplasty. JBJS (Am) 64(A(9)):1295–1306
Fender D, Harper WM, Thompson JR, Gregg PJ (1997) Mortality and fatal pulmonary embolism following primary total hip replacement. JBJS (Br) 79-B:896–899
Sculco TP, Colwell CW, Pellegrini VD, Westrich GH, Bottner F (2002) Prophylaxis against venous thromboembolic disease in patients having a total hip or knee arthroplasty. Instructional course lecture. JBJS (Am) 84(A (3)):466–477
Geerts WH, Heit JA, Clagett GP et al (2001) Prevention of venous thromboembolism. Sixth ACCP consensus conference on antithrombotic therapy. Chest 119:132S–175S
Demos HA, Rorabeck CH, Bourne RB, MacDonald SJ, McCalden RW (2001) Instability in primary total hip arthroplasty with the direct lateral approach. Clin Orthop Rel Res 393:p168–p180
Goldstein WM, Gleason TF, Kopplin M, Branson JJ (2001) Prevalence of dislocation after total hip arthroplasty through a posterolateral approach with partial capsulotomy and capsulorrhaphy. JBJS (Am) 83-A Suppl 2 (Pt 1):2–7
Mohanty SS, Kay PR (2004) Infection in total joint replacements. Why we screen MRSA when MRSE is the problem? JBJS (Br) 86-B(2):266–269
Garvin KL, Hanssen AD (1995) Infection after total hip arthroplasty. Past, present, and future. JBJS (Am) 77-A(10):1576–1588
Pulmonary Embolism Prevention (PEP) Trial Collaborative Group (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet 355(921):1295–1302
Acknowledgments
The authors wish to acknowledge Aisling Mulligan at the Economic and Social Research Institute who provided all the national audit figures in this article. We would also like to thank all those who responded to our survey.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Curtin, P., Harty, J., Sheehan, E. et al. Self-reported complication rates following primary total hip arthroplasty in Ireland: fact or fiction. Ir J Med Sci 180, 167–171 (2011). https://doi.org/10.1007/s11845-010-0576-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-010-0576-1